2 options
Hatch-Waxman Act : Proposed Legislative Changes Affecting Pharmaceutical Patents.
- Format:
- Book
- Government document
- Author/Creator:
- Library of Congress. Congressional Research Service.
- Language:
- English
- Subjects (All):
- Drugs.
- Medical laws and legislation.
- Patents.
- Physical Description:
- 1 online resource (12 pages) : digital, PDF file
- monochrome
- Place of Publication:
- [Place of publication not identified] : [publisher not identified], 2003.
- System Details:
- System requirements: PDF reader software.
- text file
- Summary:
- Reviews proposed legislative changes to the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products. Discusses general provisions of the law, selected patent-related issues, FTC report on abbreviated new drug applications, proposed FDA rule change regarding requirements for listing pharmaceutical patents in the Orange Book, and various legislative proposals in the 108th Congress to amend the Hatch-Waxman Act.
- Notes:
- CRS Report.
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.
- Other Format:
- Microfiche version: Library of Congress. Congressional Research Service. Hatch-Waxman Act
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.